Publications by authors named "Stuart N Atkinson"

Claim this Profile
S
Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancer.
Joseph F Renzulli, Scott T Tagawa, Stuart N Atkinson, Deborah M Boldt-Houle, Judd W Moul

BJUI Compass· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data.
E David Crawford, Przemyslaw W Twardowski, Raoul S Concepcion, Jason M Hafron, Richard G Harris, Stuart N Atkinson

J Urol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants.
Majid Vakily, Jingtao Wu, Stuart N Atkinson

J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects.
Weijiang Zhang, Jingtao Wu, Stuart N Atkinson

J Clin Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials.
Majid Vakily, Weijiang Zhang, Jingtao Wu, Stuart N Atkinson, Darcy Mulford

Curr Med Res Opin· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis